Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Enhancement of neoantigen presentation of mRNA cancer vaccines using photosensitive LNPs
EF 2025-26
Résumé
In recent years, cancer vaccines have emerged as a new, promising therapy for significantly reducing the cancer recurrence in patients. These vaccines function by delivering tumor-specific protein markers called neoantigens to the patient’s body, teaching the patient’s own immune cells to recognize and destroy cancer cells. Discovery of lipid nanoparticles (LNP) and their clinical success with COVID-19 vaccines have especially enhanced the potential for cancer vaccines. LNPs are lipid-based delivery vehicles that can stably deliver therapeutic messenger RNA (mRNA), which contains the genetic code for the neoantigens that allows their production in patient cells. However, a challenge remains. LNPs enter cells through an internal bubble called endosomes, where mRNA must first escape from to produce neoantigens and trigger a subsequent immune response. Currently, the proportion of mRNA that enters the cell and gets expressed remains mere 2%, which results in an insufficient neoantigen production and prevents the activation of a strong anti-cancer immune response.
To overcome this, I introduce a photosensitive lipid into the LNP formulation, which can transiently and safely disrupt the endosomal wall upon exposure to a laser. This enhanced escape mechanism will increase the amount of therapeutic mRNA released into the cell, leading to increased neoantigen expression and immune response compared to previously established LNPs. I will assess this by comparing the cell surface antigen expression levels from photosensitive or standard LNP formulations with or without laser irradiation. I am confident that my work will contribute to developing more effective cancer vaccines for preventing recurrence and improving long-term patient survival in Canada.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572646
Name
Goo Garyeong
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Enhancement of neoantigen presentation of mRNA cancer vaccines using photosensitive LNPs
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cancer Vaccine; Endosomal Escape; Laser; Lipid Nanoparticles; Mrna Therapy; Nanomedicine; Nanoparticles; Neoantigen Expression; Photosensitizer; Porphyrin
Abstract
In recent years, cancer vaccines have emerged as a new, promising therapy for significantly reducing the cancer recurrence in patients. These vaccines function by delivering tumor-specific protein markers called neoantigens to the patient’s body, teaching the patient’s own immune cells to recognize and destroy cancer cells. Discovery of lipid nanoparticles (LNP) and their clinical success with COVID-19 vaccines have especially enhanced the potential for cancer vaccines. LNPs are lipid-based delivery vehicles that can stably deliver therapeutic messenger RNA (mRNA), which contains the genetic code for the neoantigens that allows their production in patient cells. However, a challenge remains. LNPs enter cells through an internal bubble called endosomes, where mRNA must first escape from to produce neoantigens and trigger a subsequent immune response. Currently, the proportion of mRNA that enters the cell and gets expressed remains mere 2%, which results in an insufficient neoantigen production and prevents the activation of a strong anti-cancer immune response.
To overcome this, I introduce a photosensitive lipid into the LNP formulation, which can transiently and safely disrupt the endosomal wall upon exposure to a laser. This enhanced escape mechanism will increase the amount of therapeutic mRNA released into the cell, leading to increased neoantigen expression and immune response compared to previously established LNPs. I will assess this by comparing the cell surface antigen expression levels from photosensitive or standard LNP formulations with or without laser irradiation. I am confident that my work will contribute to developing more effective cancer vaccines for preventing recurrence and improving long-term patient survival in Canada.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Goo, Garyeong
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~